Atlas Trials

Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment

Clinical trial NCT00337350 · COMPLETED

Trial details

NCT number
NCT00337350
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-09-01
Primary completion
2011-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.